Companies: 10,795·Total market cap: $144.5T
Cyclo Therapeutics, Inc.

Cyclo Therapeutics, Inc.

CYTHNASDAQHealthcare
$0.72
+$0.00(+0.00%)
Market Cap$23589778
P/E Ratio
52W High$1.6199
52W Low$0.55
Overview

Cyclo Therapeutics, Inc.(CYTH)股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

cyth · 股价预测 · 3 位分析师(近3月)· FMP · 更新于 2025年6月24日

分析师评级与共识

基于过去 3 个月内 3 位华尔街分析师

SellBuy

Hold

3 位分析师

共识

评级分布

Strong Buy
0
Buy
1
Hold
2
Sell
0
Strong Sell
0
合计: 3 · 买入占比: 33.3%

12 个月目标价

High

$0.95

Consensus

$0.95

+31.8% upside

Low

$0.95

Median: $0.95 · Last Close: $0.72

Cyclo Therapeutics, Inc.(CYTH)的分析师共识为 Hold,基于过去 3 个月内 3 位华尔街分析师的评级。CYTH 的 12 个月平均目标价为 $0.95,相对当前价 $0.72 代表 +31.8% 的潜在上行空间。

12 个月目标价预测

历史收盘价 + 分析师 12 个月目标价预测区间

分析师目标价覆盖不足,无法为该股票生成预测图表。

短期股价预测

算法生成 · 每日更新

DatePredicted PriceChange
2026-06-10$0.730.94%

1-day model range: $0.72–$0.73. Peak: $0.73 (+0.94%).

长期股价预测

⚠️ 在满 252 个交易日历史(IPO/上市时间较短)前不展示长期预测;短期标签页仍可能显示模型输出。

基于技术分析的股价预测

14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明

Market Sentiment

NEUTRAL

Based on 14 technical indicators

36%57%7%
5Buy
8Neutral
1Sell
RSI (14)46.3Neutral
MACDNEUTRAL

Refreshes daily from EOD close

Moving Averages · CYTH · Jun 9, 2026

Simple Moving Average (SMA)
MA 5$0.71BUY
MA 10$0.69BUY
MA 20$0.71BUY
MA 50$0.00NEUTRAL
MA 100$0.00NEUTRAL
MA 200$0.00NEUTRAL
Current $CYTH · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$0.71BUY
EMA 10$0.71BUY
EMA 20$0.74SELL
EMA 50$0.00NEUTRAL
EMA 100$0.00NEUTRAL
EMA 200$0.00NEUTRAL
Current $CYTH · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
Maxim Group2024-08-27
Downgrade ↓
BuyHold
Ascendiant Capital2024-08-26
Maintains
BuyBuy
HC Wainwright & Co.2024-08-23
Downgrade ↓
BuyNeutral
HC Wainwright & Co.2024-08-16
Maintains
BuyBuy
HC Wainwright & Co.2024-05-31
Maintains
BuyBuy
Maxim Group2023-09-27
Upgrade ↑
HoldBuy
Maxim Group2023-09-26
Upgrade ↑
HoldBuy
Maxim Group2023-03-21
Downgrade ↓
BuyHold
Maxim Group2023-03-20
Downgrade ↓
BuyHold
Maxim Group2020-12-17
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on Cyclo Therapeutics, Inc. (CYTH) stock. Of the recent 10 rating actions, 2 were upgrades and 4 were downgrades. 3 analysts currently cover CYTH.

分析师推荐趋势

Buy ratings12↑ +1
Hold ratings02↑ +2
Sell ratings00

CYTH analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 2 per month.

财务预测:EPS 与营收一致预期

Revenue This Year

$1M

↓ 96.1% YoY

Revenue Next Year

$2M

↑ 60.0% YoY

EPS This Year

$-0.59

EPS Next Year

$-0.50

↓ 15.3% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast CYTH EPS of $-0.59 for the current fiscal year, based on estimates from 2 analysts. The CYTH revenue forecast is $1M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

CYTH 股价预测由两类独立数据源支撑:来自 3 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。CYTH 的共识目标价为 $0.95(+31.8% 上行空间),分析师共识为 Hold。

CYTH 的短期预测(明日)为 $0.73(+0.94%)。

Cyclo Therapeutics, Inc. 在 NASDAQ 上市,代码 CYTH。CYTH 在 2027 年的整体展望偏中性/分化,在覆盖分析师中约 33% 对应 Hold 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

CYTH 预测 · 8 个问题

根据 3 位华尔街分析师,CYTH 的 12 个月平均目标价为 $0.95,最高 $0.95、最低 $0.95。若有图表,中位目标价可在上方查看。相对当前价 $0.72,隐含约 +31.8% 的上行空间。

CYTH 目标价CYTH 分析师目标价CYTH 12个月目标价目标价 CYTH

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.